RPID — Rapid Micro Biosystems Share Price
Last trade - 00:00- $38.62m
- -$30.48m
- $22.52m
- 25
- 55
- 46
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.41 | ||
| Price to Tang. Book | 0.41 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.56 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -54.03% | ||
| Return on Equity | -43.09% | ||
| Operating Margin | -219.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 16.51 | 16.08 | 23.23 | 17.13 | 22.52 | 27.26 | 35.15 | 8.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Directors
- Jeffrey Schwartz NEC (42)
- Robert Spignesi PRE (52)
- Sean Wirtjes CFO (51)
- John Wilson COO (54)
- Victoria Vezina CHO (54)
- Michael Beaulieu VPR
- Jonathan Paris GCN (46)
- Andy Keys OTH
- Richard Kollender DRC (51)
- David Hirsch IND (50)
- Melinda Litherland IND (63)
- Inese Lowenstein IND
- Natale Ricciardi IND (72)
- Alexander Schmitz IND (46)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 29th, 2006
- Public Since
- July 15th, 2021
- No. of Shareholders
- 36
- No. of Employees
- 193
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 42,914,151
- Address
- 25 Hartwell Avenue, LEXINGTON, 02421
- Web
- https://www.rapidmicrobio.com/
- Phone
- +1 9783493200
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for RPID
Similar to RPID
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
As of Today at 22:52 UTC, shares in Rapid Micro Biosystems are trading at $0.90. This share price information is delayed by 15 minutes.
Shares in Rapid Micro Biosystems last closed at $0.90 and the price had moved by -17.43% over the past 365 days. In terms of relative price strength the Rapid Micro Biosystems share price has underperformed the S&P500 Index by -38.3% over the past year.
The overall consensus recommendation for Rapid Micro Biosystems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreRapid Micro Biosystems does not currently pay a dividend.
Rapid Micro Biosystems does not currently pay a dividend.
Rapid Micro Biosystems does not currently pay a dividend.
To buy shares in Rapid Micro Biosystems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.90, shares in Rapid Micro Biosystems had a market capitalisation of $38.62m.
Here are the trading details for Rapid Micro Biosystems:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: RPID
Based on an overall assessment of its quality, value and momentum Rapid Micro Biosystems is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Rapid Micro Biosystems is $4.75. That is 427.78% above the last closing price of $0.90.
Analysts covering Rapid Micro Biosystems currently have a consensus Earnings Per Share (EPS) forecast of -$1.08 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rapid Micro Biosystems. Over the past six months, its share price has underperformed the S&P500 Index by -15.21%.
As of the last closing price of $0.90, shares in Rapid Micro Biosystems were trading +3.39% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rapid Micro Biosystems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rapid Micro Biosystems' management team is headed by:
- Jeffrey Schwartz - NEC
- Robert Spignesi - PRE
- Sean Wirtjes - CFO
- John Wilson - COO
- Victoria Vezina - CHO
- Michael Beaulieu - VPR
- Jonathan Paris - GCN
- Andy Keys - OTH
- Richard Kollender - DRC
- David Hirsch - IND
- Melinda Litherland - IND
- Inese Lowenstein - IND
- Natale Ricciardi - IND
- Alexander Schmitz - IND